site:jnm.snmjournals.org

Nuclear Imaging Strategies to Evaluate Cytokine Production in Autoimmune, Inflammatory, and Neoplastic Diseases: A Review of Current Preclinical Research

Cytokines are small proteins that directly regulate immune cell proliferation and signaling. An improved understanding of cytokine expression in specific microenvironments provides critical insights ...

Journal of Nuclear Medicine

Checking for AI-Generated Content with AI: The Reverse Turing Test

Large language models have become enormously powerful tools for summarizing existing knowledge and generating text, figures, and references for scientific publications. This power can be abused to ...

snmjournals.org

Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer

Journal of Nuclear Medicine October 2025, jnumed.125.270825; DOI: https://doi.org/10.2967/jnumed.125.270825 ...

Journal of Nuclear Medicine

From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials

Theranostics and radiopharmaceutical therapies are rapidly transforming the medical landscape, and the neuro-oncology community is observing these developments with great interest. In a field characte ...

snmjournals.org

Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine July 2025, jnumed.125.269729; DOI: https://doi.org/10.2967/jnumed.125.269729 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Nuclear Imaging Strategies to Evaluate Cytokine Production in Autoimmune, Inflammatory, and Neoplastic Diseases: A Review of Current Preclinical Research

Checking for AI-Generated Content with AI: The Reverse Turing Test

Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer

From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials

Biodistribution and Radiation Dosimetry of

CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction

Artificial Intelligence–Powered Quantification of Flortaucipir PET for Detecting Tau Pathology

Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy

Evaluating Radiotheranostic Targets for Endometrial Cancer

Lymphoma Therapy Response Assessment with Low-Dose

Clinical Validation of Deep Learning for Image Restoration of Ultra-Low-Count

Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer